Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Leukemia & Lymphoma
|
July 12, 2003
Extramedullary liver plasmacytoma a rare presentation
Maria Teresa Petrucci, Maria Cristina Tirindelli, Marianna De Muro, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
November 21, 2017
Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis
Silvia Majore, Maria Carmela Bonaccorsi di Patti, Michele Valiante, et al.
Cancer
|
June 22, 2011
Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drug
Roberto Latagliata, Antonio Spadea, Michele Cedrone, et al.
Leukemia & Lymphoma
|
May 4, 2011
Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant
Francesco Spina, Vittorio Montefusco, Claudia Crippa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance
Francesca Rossi, Maria Teresa Petrucci, Andrea Guffanti, et al.
Therapeutic Advances in Hematology
|
September 11, 2023
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy
Marianna De Muro, Annelot Julia Janssen, Sergio Amadori, et al.
Blood Cancer Journal
|
March 7, 2021
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program
Alessandro Rambaldi, Alessandra Iurlo, Alessandro M Vannucchi, et al.
Leukemia Research
|
December 23, 2018
Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?
Ambra Di Veroli, Alessia Campagna, Marianna De Muro, et al.
European Journal of Haematology
|
August 17, 2015
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase
Roberto Latagliata, Chiara Montagna, Raffaele Porrini, et al.
American Journal of Hematology
|
February 1, 2014
Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients
Marco Montanaro, Roberto Latagliata, Michele Cedrone, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Leukemia & Lymphoma
|
July 12, 2003
Extramedullary liver plasmacytoma a rare presentation
Maria Teresa Petrucci, Maria Cristina Tirindelli, Marianna De Muro, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
November 21, 2017
Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis
Silvia Majore, Maria Carmela Bonaccorsi di Patti, Michele Valiante, et al.
Cancer
|
June 22, 2011
Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drug
Roberto Latagliata, Antonio Spadea, Michele Cedrone, et al.
Leukemia & Lymphoma
|
May 4, 2011
Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant
Francesco Spina, Vittorio Montefusco, Claudia Crippa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance
Francesca Rossi, Maria Teresa Petrucci, Andrea Guffanti, et al.
Therapeutic Advances in Hematology
|
September 11, 2023
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy
Marianna De Muro, Annelot Julia Janssen, Sergio Amadori, et al.
Blood Cancer Journal
|
March 7, 2021
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program
Alessandro Rambaldi, Alessandra Iurlo, Alessandro M Vannucchi, et al.
Leukemia Research
|
December 23, 2018
Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?
Ambra Di Veroli, Alessia Campagna, Marianna De Muro, et al.
European Journal of Haematology
|
August 17, 2015
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase
Roberto Latagliata, Chiara Montagna, Raffaele Porrini, et al.
American Journal of Hematology
|
February 1, 2014
Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients
Marco Montanaro, Roberto Latagliata, Michele Cedrone, et al.
Page
of 2